Abstract
Auranofin (AF) was given to 2 groups of patients, one receiving 1 mg daily (56 patients), the other 9 mg (60 patients) in a double-blind manner. Significantly fewer patients on 1 mg (7%) reduced dosage or dropped out because of side effects than did those on high dose (27%; p < 0.05). Dropouts related to skin rash while dose reduction was necessitated by self-limiting diarrhea. Significantly more patients on low dose dropped out because of lack of efficacy than did those on high dose.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 146-148 |
| Number of pages | 3 |
| Journal | Journal of Rheumatology |
| Volume | 9 |
| Issue number | Suppl. 8 |
| State | Published - 1982 |
| Externally published | Yes |
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology